Table 4 Clinical and procedural outcomes
From: Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome
Parameter | Total no. of patients n = 40 |
|---|---|
Clinical successa | 40/40 (100) |
MAE within 30 days | |
Deathb | 0/40 (0.0) |
Myocardial infarction | 0/40 (0.0) |
Major amputation | 0/40 (0.0) |
Acute thrombotic occlusion | 1/40 (2.5) |
Primary patency | |
3 months | 97 (94–100) |
6 months | 97 (94–100) |
1 year | 97 (94–100) |
2 years | 92 (86–98) |
3 years | 92 (86–98) |
4 years | 92 (86–98) |
5 years | 92 (86–98) |
6 years | 92 (86–98) |
Secondary patency | |
3 months | 97 (94–100) |
6 months | 97 (94–100) |
1 year | 97 (94–100) |
2 years | 97 (94–100) |
3 years | 97 (94–100) |
4 years | 97 (94–100) |
5 years | 97 (94–100) |
6 years | 97 (94–100) |
cdTLR | |
Total | 2/40 (5.0) |
Endovascular treatment | 2/40 (5.0) |
Surgical treatment | 0/40 (0.0) |
Major amputation | 0/40 (0.0) |
Minor amputation | 0/40 (0.0) |